Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization

Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.

Read the full article on diagnosticimaging.com